Open Beta
MetriLume

US marketsIMA

SEC-sourced researchBeta

IMA

ImageneBio, Inc.

Company comparison ↗

Data passport

CIK
0001835579
Exchange
Nasdaq
Business activity
— · SIC 2836
Financial inputs
6/6
Filing date
Mar 10, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 3,500,000.0000 USD; December 2025: 800,000.0000 USD3.5M USD0 USD0December 2024December 2025
IMA · Exact amounts and source periods · USD
Period endRevenueFiling date
December 20243,500,000.0000Mar 10, 2026
December 2025800,000.0000Mar 10, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 2025800,000.0000-45,349,000.0000-47,844,000.0000152,976,000.000019,837,000.0000Mar 10, 2026
December 20243,500,000.0000-36,568,000.0000-21,319,000.000015,922,000.000017,448,000.0000Mar 10, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenueFromContractWithCustomerExcludingAssessedTax$800KDecember 2025Mar 10, 202610-K
Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax$3.5MDecember 2024Mar 10, 202610-K
Net incomeNetIncomeLoss-$45.35MDecember 2025Mar 10, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities-$47.84MDecember 2025Mar 10, 202610-K
Total assetsAssets$152.98MDecember 2025Mar 10, 202610-K
Total liabilitiesLiabilities$19.84MDecember 2025Mar 10, 202610-K

New filings

Explore methodology ↗